vimarsana.com

Page 3 - ஆய்வகம் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Abbott Laboratories (NYSE:ABT) - The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma s Epidiolex

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Abbott Laboratories (NYSE:ABT) - The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma s Epidiolex
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ADVM) - The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), (ADVM) - The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Zai Lab Announces Financial Results for Second-half and Full-year 2020

Zai Lab Announces Financial Results for Second-half and Full-year 2020 March 01, 2021 07:00 ET | Source: Zai Lab Limited Zai Lab Limited Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates. “2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder, Chairperson and Chief Executive Officer of Zai Lab. “We successfully launched ZEJULA for both second-line and first-line ovarian cancer and Optune for glioblastoma in China. We submitted NDAs and were granted priority reviews by China’s National Medical Products Administration (NMPA) for both QINLOCK for advanced gastrointestinal stromal tumors (GIST) and NUZYRA for community-acquire

15 Fastest Growing Biotech Companies in the US

15 Fastest Growing Biotech Companies in the US In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest Growing Biotech Companies in the US. Biotechnology is one of the most consequential domains of the healthcare industry. Biotechnology uses biology and the functions of living organisms to make new treatments and technology for healthcare. Advances in biotechnology are stepping stones for human progress in key areas like genetics, DNA sequencing, recombinant gene techniques, applied immunology and diagnostics. Data shows that global biotechnology market is expected to cross $720 billion in value by 2025.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.